136 related articles for article (PubMed ID: 29963143)
1. Global lipidomics reveals two plasma lipids as novel biomarkers for the detection of squamous cell lung cancer: A pilot study.
Yu Z; Chen H; Zhu Y; Ai J; Li Y; Gu W; Borgia JA; Zhang J; Jiang B; Chen W; Deng Y
Oncol Lett; 2018 Jul; 16(1):761-768. PubMed ID: 29963143
[TBL] [Abstract][Full Text] [Related]
2. Global lipidomics identified plasma lipids as novel biomarkers for early detection of lung cancer.
Yu Z; Chen H; Ai J; Zhu Y; Li Y; Borgia JA; Yang JS; Zhang J; Jiang B; Gu W; Deng Y
Oncotarget; 2017 Dec; 8(64):107899-107906. PubMed ID: 29296211
[TBL] [Abstract][Full Text] [Related]
3. Application of Lipidomics for Assessing Tissue Lipid Profiles of Patients With Squamous Cell Carcinoma.
Zeng W; Zheng W; Hu S; Zhang J; Zhang W; Xu J; Yu D; Peng J; Zhang L; Gong M; Wei Y
Technol Cancer Res Treat; 2021; 20():15330338211049903. PubMed ID: 34761720
[No Abstract] [Full Text] [Related]
4. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
[TBL] [Abstract][Full Text] [Related]
5. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Chen X; Chen H; Dai M; Ai J; Li Y; Mahon B; Dai S; Deng Y
Oncotarget; 2016 Jun; 7(24):36622-36631. PubMed ID: 27153558
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical panel consisting of EZH2, C-KIT, and CD205 is useful for distinguishing thymic squamous cell carcinoma from type B3 thymoma.
Kim BS; Kim JK; Kang CH; Kim YT; Jung KC; Won JK
Pathol Res Pract; 2018 Mar; 214(3):343-349. PubMed ID: 29487009
[TBL] [Abstract][Full Text] [Related]
7. Plasma small ncRNA pair panels as novel biomarkers for early-stage lung adenocarcinoma screening.
Dou Y; Zhu Y; Ai J; Chen H; Liu H; Borgia JA; Li X; Yang F; Jiang B; Wang J; Deng Y
BMC Genomics; 2018 Jul; 19(1):545. PubMed ID: 30029594
[TBL] [Abstract][Full Text] [Related]
8. Integrative Metabolomic and Lipidomic Profiling of Lung Squamous Cell Carcinoma for Characterization of Metabolites and Intact Lipid Species Related to the Metastatic Potential.
Lee H; Lee H; Park S; Kim M; Park JY; Jin H; Oh K; Bae J; Yang Y; Choi HK
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439333
[TBL] [Abstract][Full Text] [Related]
9. Screening of Lipids for Early Triage and Dose Estimation after Acute Radiation Exposure in Rat Plasma Based on Targeted Lipidomics Analysis.
Xi C; Zhao H; Lu X; Cai TJ; Li S; Liu KH; Tian M; Liu QJ
J Proteome Res; 2021 Jan; 20(1):576-590. PubMed ID: 33200940
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy.
Nan Y; Yang S; Tian Y; Zhang W; Zhou B; Bu L; Huo S
Med Oncol; 2009; 26(2):215-21. PubMed ID: 18988000
[TBL] [Abstract][Full Text] [Related]
11. A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer.
Shen S; Yang L; Li L; Bai Y; Cai C; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():41-48. PubMed ID: 29028617
[TBL] [Abstract][Full Text] [Related]
12. Expression of p63 and CK5/6 in early-stage lung squamous cell carcinoma is not only an early diagnostic indicator but also correlates with a good prognosis.
Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Xiong H; Liang Z; Yan W; Chen K
Thorac Cancer; 2015 May; 6(3):288-95. PubMed ID: 26273374
[TBL] [Abstract][Full Text] [Related]
13. LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma.
Liu X; Zhang M; Cheng X; Liu X; Sun H; Guo Z; Li J; Tang X; Wang Z; Sun W; Zhang Y; Ji Z
Front Oncol; 2020; 10():717. PubMed ID: 32500026
[TBL] [Abstract][Full Text] [Related]
14. Combined double CK5/P63 stain: useful adjunct test for diagnosing pulmonary squamous cell carcinoma.
Fatima N; Cohen C; Lawson D; Siddiqui MT
Diagn Cytopathol; 2012 Nov; 40(11):943-8. PubMed ID: 21472873
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry.
Hmmier A; O'Brien ME; Lynch V; Clynes M; Morgan R; Dowling P
BBA Clin; 2017 Jun; 7():97-104. PubMed ID: 28331811
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma.
Wang L; Wang X; Li Y; Hou Y; Sun F; Zhou S; Li C; Zhang B
Oncotarget; 2017 Nov; 8(54):92324-92332. PubMed ID: 29190918
[TBL] [Abstract][Full Text] [Related]
17. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
[TBL] [Abstract][Full Text] [Related]
18. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
Guo S; Qiu L; Wang Y; Qin X; Liu H; He M; Zhang Y; Li Z; Chen X
Anal Bioanal Chem; 2014 Jul; 406(18):4357-70. PubMed ID: 24842401
[TBL] [Abstract][Full Text] [Related]
19. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
[TBL] [Abstract][Full Text] [Related]
20. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
